Autosomal dominant polycystic kidney disease (ADPKD)
Hyperuricemia and deterioration of renal function in autosomal dominant polycystic kidney disease
8
Magnetic resonance imaging is effective for evaluating the therapeutic effect of tolvaptan on total kidney volume in patients with autosomal dominant polycystic kidney disease
6
Familial Arachnoid Cysts in Association With Autosomal Dominant Polycystic Kidney Disease
5
Total kidney and liver volume is a major risk factor for malnutrition in ambulatory patients with autosomal dominant polycystic kidney disease
10
Modelling the long-term benefits of tolvaptan therapy on renal function decline in autosomal dominant polycystic kidney disease: an exploratory analysis using the ADPKD outcomes model
9
A systematic review of the predictors of disease progression in patients with autosomal dominant polycystic kidney disease
16
STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease.
25
A Study on Clinical Profile and Extrarenal Manifestations of Autosomal Dominant Polycystic Kidney Disease
105
Autosomal dominant polycystic kidney disease in a family with mosaicism and hypomorphic allele
6
Real world costs of autosomal dominant polycystic kidney disease in the Nordics
9
Urine proteome of autosomal dominant polycystic kidney disease patients
13
<p>Autosomal dominant polycystic kidney disease: updated perspectives</p>
12
A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model
12
Risk of intracranial hemorrhage associated with autosomal dominant polycystic kidney disease in patients with end stage renal disease
8
Urine Fetuin A is a biomarker of autosomal dominant polycystic kidney disease progression
11
Chronic asymptomatic pyuria precedes overt urinary tract infection and deterioration of renal function in autosomal dominant polycystic kidney disease
9
<p>Management of Autosomal Dominant Polycystic Kidney Disease (ADPKD) During Pregnancy: Risks and Challenges</p>
14
Autosomal dominant polycystic kidney disease with ectopic unilateral multicystic dysplastic kidney
5
Functional polycystin 1 dosage governs autosomal dominant polycystic kidney disease severity
18
Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease
11